BALYASNY ASSET MANAGEMENT L.P. - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$15,613,000
-68.3%
358,680
-68.3%
0.05%
-67.1%
Q1 2022$49,238,000
+33.8%
1,130,360
+35.4%
0.16%
+24.0%
Q4 2021$36,809,000
-2.6%
834,667
-53.9%
0.12%
-20.4%
Q3 2021$37,782,000
+264.9%
1,811,455
+596.7%
0.16%
+220.4%
Q2 2021$10,353,000
+703.8%
260,000
+160.0%
0.05%
+716.7%
Q1 2021$1,288,000
-68.9%
100,000
-8.5%
0.01%
-87.8%
Q1 2020$4,141,000
-90.6%
109,285
-90.3%
0.05%
-73.4%
Q1 2018$43,954,000
+16.5%
1,125,000
+5.8%
0.18%
+55.9%
Q4 2017$37,726,000
+326.1%
1,063,591
+387.7%
0.12%
+237.1%
Q3 2017$8,853,000
-25.3%
218,063
-22.4%
0.04%
-36.4%
Q1 2017$11,846,000
+972.0%
280,969
+879.0%
0.06%
+816.7%
Q4 2016$1,105,000
-78.1%
28,700
-75.4%
0.01%
-79.3%
Q3 2016$5,038,000
-86.1%
116,811
-86.0%
0.03%
-87.6%
Q2 2016$36,142,000
+179.8%
833,925
+161.8%
0.23%
+203.9%
Q1 2016$12,917,000
+149.7%
318,555
+136.8%
0.08%
+102.6%
Q3 2015$5,172,000
-43.6%
134,519
-38.9%
0.04%
-33.3%
Q2 2015$9,170,000
-68.8%
220,171
-65.6%
0.06%
-75.0%
Q3 2014$29,426,000
+697.2%
640,121
+826.5%
0.23%
+442.9%
Q1 2014$3,691,000
-60.7%
69,088
-63.2%
0.04%
-73.4%
Q2 2013$9,390,000187,9080.16%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2021
NameSharesValueWeighting ↓
Sio Capital Management, LLC 325,823$11,557,0006.52%
KAHN BROTHERS GROUP INC 1,139,163$40,406,111,0006.35%
Chubb Ltd 400,000$14,188,0006.18%
Healthcare Value Capital, LLC 50,000$1,774,0005.40%
CLARK ESTATES INC/NY 650,000$23,056,0003.81%
PVG ASSET MANAGEMENT CORP 220,450$7,819,361,0003.57%
Martin Capital Partners, LLC 88,195$3,128,0003.25%
Camber Capital Management LP 1,500,000$53,205,0002.60%
EQUITY INVESTMENT CORP 2,090,120$74,137,0002.47%
Keystone Financial Planning, Inc. 129,102$4,579,0002.44%
View complete list of GLAXOSMITHKLINE PLC shareholders